TABLE 1.
Clinical characterization of HIV-1-infected participants and healthy controls
| Parameter | Datum for: |
|||
|---|---|---|---|---|
| HIV progressors | Viremic controllers | Elite controllers | Healthy donors | |
| No. of subjects | 16 | 12 | 8 | 9 |
| Antiretroviral therapy | Naive | Naive | Naive | |
| Age (yrs), mean ± SD | 39 ± 9 | |||
| Gender (male:female) | 16:00 | |||
| Duration of infection (yrs), mean ± SD | 17 ± 6.3 | |||
| CD4+ T cells/mm3, mean ± SD | 512 ± 143 | 570 ± 152 | 1,395 ± 399 | |
| CD8+ T cells/mm3, mean ± SD | 1,293 ± 520 | 1,060 ± 429 | ||
| CD4/CD8 ratio, mean ± SD | 0.52 ± 0.25 | 1.45 ± 0.58 | ||
| Median plasma HIV-1 RNA (copies/ml), mean ± SD | 19,414 ± 30,548 | 894 ± 607 | <40 | |